The Law Offices of Howard G. Smith Commences Investigation on Behalf of BioMed Realty Trust, Inc. Investors

BENSALEM, Pa.--(BUSINESS WIRE)--

Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of BioMed Realty Trust, Inc. BMR ("BioMed" or "the Company") and whether the officers and directors complied with their legal obligations to the Company and its shareholders in connection with a sale of the Company to The Blackstone Group L.P. ("Blackstone").

Under the terms of the proposed Blackstone-BioMed transaction, BioMed shareholders will receive $23.75 in cash for each share of BioMed stock they own. The investigation concerns whether the Board of BioMed breached their fiduciary duties to shareholders and whether Blackstone is underpaying for BioMed. As an example of BioMed's potential value, the Company's stock traded at $24.95 as recently as January 26, 2015 and at least one Wall Street analyst has set a price target on BioMed stock at $26.00 per share. The Law Offices of Howard G. Smith is attempting to increase BioMed shareholder value, and investors are encouraged to contact Howard G. Smith to discuss their legal rights.

If you own BioMed shares, if you have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151016006081/en/